These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 17442686

  • 1. Effect of clopidogrel on the steady-state pharmacokinetics of fluvastatin.
    Ayalasomayajula SP, Vaidyanathan S, Kemp C, Prasad P, Balch A, Dole WP.
    J Clin Pharmacol; 2007 May; 47(5):613-9. PubMed ID: 17442686
    [Abstract] [Full Text] [Related]

  • 2. Not all statins interfere with clopidogrel during antiplatelet therapy.
    Mach F, Senouf D, Fontana P, Boehlen F, Reber G, Daali Y, de Moerloose P, Sigwart U.
    Eur J Clin Invest; 2005 Aug; 35(8):476-81. PubMed ID: 16101667
    [Abstract] [Full Text] [Related]

  • 3. Steady-state pharmacokinetics of fluvastatin in healthy subjects following a new extended release fluvastatin tablet, Lescol XL.
    Barilla D, Prasad P, Hubert M, Gumbhir-Shah K.
    Biopharm Drug Dispos; 2004 Mar; 25(2):51-9. PubMed ID: 14872552
    [Abstract] [Full Text] [Related]

  • 4. Clopidogrel does not affect the pharmacokinetics of theophylline.
    Caplain H, Thebault JJ, Necciari J.
    Semin Thromb Hemost; 1999 Mar; 25 Suppl 2():65-8. PubMed ID: 10440427
    [Abstract] [Full Text] [Related]

  • 5. Multiple antiplatelet effects of clopidogrel are not modulated by statin type in patients undergoing percutaneous coronary intervention.
    Smith SM, Judge HM, Peters G, Storey RF.
    Platelets; 2004 Dec; 15(8):465-74. PubMed ID: 15763887
    [Abstract] [Full Text] [Related]

  • 6. The effects of laropiprant, a selective prostaglandin D₂ receptor 1 antagonist, on the antiplatelet activity of clopidogrel or aspirin.
    Dallob A, Luo WL, Luk JM, Ratcliffe L, Johnson-Levonas AO, Schwartz JI, Dishy V, Kraft WK, De Hoon JN, Van Hecken A, De Lepeleire I, Radziszewski W, Wagner JA, Lai E.
    Platelets; 2011 Dec; 22(7):495-503. PubMed ID: 21526889
    [Abstract] [Full Text] [Related]

  • 7. Effect of ranitidine on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel.
    Small DS, Farid NA, Li YG, Ernest CS, Payne CD, Salazar DE, Winters KJ.
    Curr Med Res Opin; 2008 Aug; 24(8):2251-7. PubMed ID: 18786302
    [Abstract] [Full Text] [Related]

  • 8. Clopidogrel loading dose regimens: kinetic profile of pharmacodynamic response in healthy subjects.
    Savcic M, Hauert J, Bachmann F, Wyld PJ, Geudelin B, Cariou R.
    Semin Thromb Hemost; 1999 Aug; 25 Suppl 2():15-9. PubMed ID: 10440417
    [Abstract] [Full Text] [Related]

  • 9. Bioequivalence and tolerability of two clopidogrel salt preparations, besylate and bisulfate: a randomized, open-label, crossover study in healthy Korean male subjects.
    Kim SD, Kang W, Lee HW, Park DJ, Ahn JH, Kim MJ, Kim EY, Kim SW, Nam HS, Na HJ, Yoon YR.
    Clin Ther; 2009 Apr; 31(4):793-803. PubMed ID: 19446152
    [Abstract] [Full Text] [Related]

  • 10. Interaction of clopidogrel and statins in secondary prevention after cerebral ischaemia - a randomized, double-blind, double-dummy crossover study.
    Siepmann T, Heinke D, Kepplinger J, Barlinn K, Gehrisch S, Grählert X, Schwanebeck U, Reichmann H, Puetz V, Bodechtel U, Gahn G.
    Br J Clin Pharmacol; 2014 Nov; 78(5):1058-66. PubMed ID: 24803100
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Repeated-dose pharmacodynamics of clopidogrel in healthy subjects.
    Thebault JJ, Kieffer G, Lowe GD, Nimmo WS, Cariou R.
    Semin Thromb Hemost; 1999 Nov; 25 Suppl 2():9-14. PubMed ID: 10440416
    [Abstract] [Full Text] [Related]

  • 13. Influence of CYP2C9 polymorphisms on the pharmacokinetics and cholesterol-lowering activity of (-)-3S,5R-fluvastatin and (+)-3R,5S-fluvastatin in healthy volunteers.
    Kirchheiner J, Kudlicz D, Meisel C, Bauer S, Meineke I, Roots I, Brockmöller J.
    Clin Pharmacol Ther; 2003 Aug; 74(2):186-94. PubMed ID: 12891229
    [Abstract] [Full Text] [Related]

  • 14. Clopidogrel antiplatelet activity is independent of age and presence of atherosclerosis.
    Denninger MH, Necciari J, Serre-Lacroix E, Sissmann J.
    Semin Thromb Hemost; 1999 Aug; 25 Suppl 2():41-5. PubMed ID: 10440422
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Long-term activity of clopidogrel: a three-month appraisal in healthy volunteers.
    Caplain H, Cariou R.
    Semin Thromb Hemost; 1999 Aug; 25 Suppl 2():21-4. PubMed ID: 10440418
    [Abstract] [Full Text] [Related]

  • 18. The difference in pharmacokinetics and pharmacodynamics between extended-release fluvastatin and immediate-release fluvastatin in healthy Chinese subjects.
    Xu HR, Chen WL, Chu NN, Li XN, Zhu JR.
    J Biomed Biotechnol; 2012 Aug; 2012():386230. PubMed ID: 22811596
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.